𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial

✍ Scribed by Albert Parés; Llorenç Caballería; Juan Rodés; Miquel Bruguera; Luis Rodrigo; Antonio García-Plaza; Joaquín Berenguer; Dolores Rodríguez-Martínez; José Mercader; Rosario Velicia

Book ID
119525653
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
818 KB
Volume
32
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Danyu Lin; Dr Mary F. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

One hundred fifty-one patients with primary biliary cirrhosis (PBC) grouped into four strata based on entry serum bilirubin (<2 mg/dL vs. 2 mg/dL or greater) and liver histology (stages I, 1 1 vs. stages 111, IV-Ludwig criteria) were randomized within each stratum to ursodiol or placebo given in a s

The canadian multicenter double-blind ra
The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
✍ E. Jenny Heathcote; Karen Cauch-Dudek; Valery Walker; Robert J. Bailey; Laurence 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 969 KB

Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile acids are retained in the liver and are hepatotoxic. Ursodeoxycholic acid is the least-known hepatotoxic bile acid, h